(PR-inside.com)
CapSureFix Novus(TM) MRI SureScan (®) 5076 Pacing Lead Approved for MR- Conditional Use in Patients with Slow Heartbeat MINNEAPOLIS - October 14, 2014 -- Medtronic today announced the U.S. Food and Drug Administration (FDA) approval of its CapSureFix Novus(TM) MRI SureScan® 5076 Lead for use with magnetic resonance imaging (MRI). The lead is approved for MRI scans positioned on any region of the body when paired with a Medtronic dual-chamber MR-conditional pacemaker. The 5076 lead, previously approved for use with Medtronic's non-MR-conditional pacemakers, has been well-received because of its handling and proven reliability. ..

More...